Literature DB >> 33840000

Perceptions of involvement in advance care planning and emotional functioning in patients with advanced cancer.

Lente L Kroon1,2,3, Janneke van Roij1,4,5,6, Ida J Korfage7, An K L Reyners8, Marieke H J van den Beuken-van Everdingen9, Marien O den Boer10, Geert-Jan Creemers11, Alexander de Graeff12, Mathijs P Hendiks13, Jarmo C B Hunting14, Wouter K de Jong15, Evelien J M Kuip16, Hanneke W M van Laarhoven17, Lobke van Leeuwen18, Anne S R van Lindert19, Caroline M P W Mandigers20, Peter Nieboer21, Annemieke van der Padt-Pruijsten22, Tineke J Smilde23, Dirkje W Sommeijer17,24, Martine F Thijs25, Marian A Tiemessen26, Allert H Vos27, Art Vreugdenhil28, Philo T Werner29, Lia van Zuylen30,31, Lonneke V van de Poll-Franse1,4,32, Natasja J H Raijmakers33,34.   

Abstract

PURPOSE: Advance Care Planning (ACP) is positively associated with the quality of care, but its impact on emotional functioning is ambiguous. This study investigated the association between perceptions of ACP involvement and emotional functioning in patients with advanced cancer.
METHODS: This study analyzed baseline data of 1,001 patients of the eQuiPe study, a prospective, longitudinal, multicenter, observational study on quality of care and quality of life in patients with advanced cancer in the Netherlands. Patients with metastatic solid cancer were asked to participate between November 2017 and January 2020. Patients' perceptions of ACP involvement were measured by three self-administered statements. Emotional functioning was measured by the EORTC-QLQ-C30. A linear multivariable regression analysis was performed while taking gender, age, migrant background, education, marital status, and symptom burden into account.
RESULTS: The majority of patients (87%) reported that they were as much involved as they wanted to be in decisions about their future medical treatment and care. Most patients felt that their relatives (81%) and physicians (75%) were familiar with their preferences for future medical treatment and care. A positive association was found between patients' perceptions of ACP involvement and their emotional functioning (b=0.162, p<0.001, 95%CI[0.095;0.229]) while controlling for relevant confounders.
CONCLUSIONS: Perceptions of involvement in ACP are positively associated with emotional functioning in patients with advanced cancer. Future studies are needed to further investigate the effect of ACP on emotional functioning. TRIAL REGISTRATION NUMBER: NTR6584 Date of registration: 30 June 2017 IMPLICATIONS FOR CANCER SURVIVORS: Patients' emotional functioning might improve from routine discussions regarding goals of future care. Therefore, integration of ACP into palliative might be promising.

Entities:  

Keywords:  Advance care planning; Advanced cancer; Palliative care; Quality of life

Year:  2021        PMID: 33840000     DOI: 10.1007/s11764-021-01020-y

Source DB:  PubMed          Journal:  J Cancer Surviv        ISSN: 1932-2259            Impact factor:   4.442


  7 in total

Review 1.  The effects of advance care planning on end-of-life care: a systematic review.

Authors:  Arianne Brinkman-Stoppelenburg; Judith A C Rietjens; Agnes van der Heide
Journal:  Palliat Med       Date:  2014-03-20       Impact factor: 4.762

2.  Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research.

Authors:  Johannes M Giesinger; Fanny L C Loth; Neil K Aaronson; Juan I Arraras; Giovanni Caocci; Fabio Efficace; Mogens Groenvold; Marieke van Leeuwen; Morten Aa Petersen; John Ramage; Krzysztof A Tomaszewski; Teresa Young; Bernhard Holzner
Journal:  J Clin Epidemiol       Date:  2019-10-19       Impact factor: 6.437

3.  The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts.

Authors:  Lonneke V van de Poll-Franse; Nicole Horevoorts; Mies van Eenbergen; Johan Denollet; Jan Anne Roukema; Neil K Aaronson; Ad Vingerhoets; Jan Willem Coebergh; Jolanda de Vries; Marie-Louise Essink-Bot; Floortje Mols
Journal:  Eur J Cancer       Date:  2011-05-27       Impact factor: 9.162

Review 4.  Early palliative care for adults with advanced cancer.

Authors:  Markus W Haun; Stephanie Estel; Gerta Rücker; Hans-Christoph Friederich; Matthias Villalobos; Michael Thomas; Mechthild Hartmann
Journal:  Cochrane Database Syst Rev       Date:  2017-06-12

Review 5.  Advance care planning for cancer patients: a systematic review of perceptions and experiences of patients, families, and healthcare providers.

Authors:  Stephanie Johnson; Phyllis Butow; Ian Kerridge; Martin Tattersall
Journal:  Psychooncology       Date:  2015-09-20       Impact factor: 3.894

6.  Advance care planning--a multi-centre cluster randomised clinical trial: the research protocol of the ACTION study.

Authors:  Judith A C Rietjens; Ida J Korfage; Lesley Dunleavy; Nancy J Preston; Lea J Jabbarian; Caroline Arnfeldt Christensen; Maja de Brito; Francesco Bulli; Glenys Caswell; Branka Červ; Johannes van Delden; Luc Deliens; Giuseppe Gorini; Mogens Groenvold; Dirk Houttekier; Francesca Ingravallo; Marijke C Kars; Urška Lunder; Guido Miccinesi; Alenka Mimić; Eugenio Paci; Sheila Payne; Suzanne Polinder; Kristian Pollock; Jane Seymour; Anja Simonič; Anna Thit Johnsen; Mariëtte N Verkissen; Esther de Vries; Andrew Wilcock; Marieke Zwakman; Agnes van der Heide Pl
Journal:  BMC Cancer       Date:  2016-04-08       Impact factor: 4.430

7.  Prospective cohort study of patients with advanced cancer and their relatives on the experienced quality of care and life (eQuiPe study): a study protocol.

Authors:  Janneke van Roij; Myrte Zijlstra; Laurien Ham; Linda Brom; Heidi Fransen; Art Vreugdenhil; Natasja Raijmakers; Lonneke van de Poll-Franse
Journal:  BMC Palliat Care       Date:  2020-09-09       Impact factor: 3.234

  7 in total
  1 in total

1.  Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium.

Authors:  Karlijn de Joode; Jolien Tol; Paul Hamberg; Marissa Cloos; Elisabeth A Kastelijn; Jessica S W Borgers; Veerle J A A Nuij; Yarne Klaver; Gerarda J M Herder; Pim G N J Mutsaers; Daphne W Dumoulin; Esther Oomen-de Hoop; Nico G J van Diemen; Eduard J Libourel; Erica J Geraedts; Gerben P Bootsma; Cor H van der Leest; Anne L Peerdeman; Karin H Herbschleb; Otto J Visser; Haiko J Bloemendal; Hanneke W M van Laarhoven; Elisabeth G E de Vries; Lizza E L Hendriks; Laurens V Beerepoot; Hans M Westgeest; Franchette W P J van den Berkmortel; John B A G Haanen; Anne-Marie C Dingemans; Astrid A M van der Veldt
Journal:  Eur J Cancer       Date:  2021-10-25       Impact factor: 9.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.